LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy. [electronic resource]
Producer: 20120404Description: 299-307 p. digitalISSN:- 1539-2864
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Choroid Diseases -- drug therapy
- Combined Modality Therapy
- Female
- Fluorescein Angiography
- Genotype
- High-Temperature Requirement A Serine Peptidase 1
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Peripheral Vascular Diseases -- drug therapy
- Pharmacogenetics
- Photochemotherapy
- Polymorphism, Single Nucleotide
- Polyps -- drug therapy
- Proteins -- genetics
- Retrospective Studies
- Serine Endopeptidases -- genetics
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.